How effective is sertraline for depression?

sertraline is a very effective treatment for depression and the treatment of depression is the main function of the drug. Studies have shown that sertraline is more effective than other competitive antidepressant drugs in the treatment of depression and that most patients have a positive reaction to the drug. More than half of the patients taking sertraline for depression go to full remission, which means that depression is no longer a problem, but can still return in the future. Generally speaking, sertraline is a common drug of first selection in patients suffering from its efficacy and relatively low example of side effects. However, patients suffering from depression and Alzheimer's disease may not be suitable for sertraline treatment. The most common type of antidepressants are selective serotonin reuptake inhibitors (SSRI). These drugs work by an examination of the level of serotonin in the brain, specifically by preventing the nerve that has released the chemical to take over it again. Neurotransmitters such as serotonin are basically chemical messengers and their levels in the brain are considered fromand related to the mood. The use of sertraline for depressive works because it makes more serotonin available to stimulate other nerves in the brain and therefore balances the patient's mood.

Studies conducted in the effects of sertraline for depression generally indicate that it works better than placebo or other common antidepressant drugs. The main remarkable difference between sertraline and other SSRIS is that sertraline has a slight effect on dopamine levels, another neurotransmitter and also on serotonin. Research has shown that other SSRI medicines such as fluoxetine are less effective than sertraline in the treatment of depression patients, and therefore the drug should be prescribed to all patients before testing other treatments. Most patients taking the medicine will go to full remission within two months and approximately 70 percent will see a significant improvement in their mood.

The main circumstance in which the use of sertral for depression is not considered the best lE -tir is when the patient also suffers from Alzheimer's disease. Studies have shown that the drug is not more effective than placebo in patients with a condition. In addition, side effects are more common in the treatment of sertraline than in placebo.

Overall, side effects occur in approximately a quarter of patients who use sertraline for depression. Most of these side effects will be smaller and very manageable, but occasionally occasional serious side effects such as irregular rhythm and allergic reactions may occur. The common side effects of sertraline include insomnia, dizziness, and loss of appetite. Giving sertraline to young patients can increase the likelihood of suicidal thinking and behavior. Any serious side effects of sertral should be discussed with a doctor.